PubRank

G Einecke

Author PubWeight™ 44.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008 8.09
2 Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2011 4.06
3 Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010 3.29
4 Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 2.25
5 De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009 2.24
6 FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008 1.94
7 NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010 1.62
8 The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant 2011 1.60
9 The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant 2010 1.54
10 The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2010 1.43
11 Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009 1.21
12 Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant 2009 1.19
13 An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010 1.16
14 Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant 2008 1.10
15 Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant 2006 1.03
16 Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant 2013 1.03
17 Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2008 1.02
18 The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008 1.01
19 Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study. Am J Transplant 2013 1.00
20 Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010 0.98
21 Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007 0.96
22 The molecular phenotype of kidney transplants. Am J Transplant 2010 0.92
23 The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. Am J Transplant 2008 0.91
24 Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010 0.90
25 Renal graft rejection or urinary tract infection? The value of myeloperoxidase, C-reactive protein, and alpha2-macroglobulin in the urine. Transplantation 1997 0.82
26 Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts. Am J Transplant 2010 0.81
27 Myeloperoxidase in urine: a new marker for distinction between rejection and urinary tract infection after renal transplantation. Transplant Proc 1997 0.80
28 Pharmacodynamic monitoring of lymphocyte proliferation and TGF-beta 1 expression at cyclosporine a (CyA) trough levels (C(0)) and 2 hours after intake (C(2)) of CyA in human renal allograft recipients. Transplant Proc 2001 0.75
29 Donor Fas is not necessary for T-cell-mediated rejection of mouse kidney allografts. Am J Transplant 2008 0.75
30 Treating type 2 diabetes in renal insufficiency: the role of pioglitazone. Int J Clin Pharmacol Ther 2003 0.75
31 Mycobacterium intracellulare bacteraemia in a double lung transplant patient. Int J Tuberc Lung Dis 2012 0.75
32 Problems of cyclosporine absorption profiling using C2-monitoring. Eur J Med Res 2005 0.75